GRAIL (NASDAQ: GRAL) CEO sells 20,000 shares in preplanned stock sale
What happened GRAIL, Inc. (NASDAQ: GRAL) said Joshua J. Ofman sold 20,000 shares on 2026-10-15. Ofman is chief executive officer and a director. The shares sold at prices from $133.12 to $138.79 per share. The Form 4 says the trades totaled about $2.74 million. After the sale, Ofman held 342,271 shares. The filing also says […]
Paylocity’s Sarowitz sells $2.93 million in shares under plan (NASDAQ: PCTY)
What happened Paylocity Holding Corp. (NASDAQ: PCTY) director and 10% owner Steven I. Sarowitz sold 17,694 shares on 2026-10-15. The Form 4 says the shares sold for about $2.93 million, at prices from $165.59 to $166.21 each. The filing is dated 2026-10-16. The form splits the sale into two lines, one for 11,600 shares and […]
Beam Therapeutics (NASDAQ: BEAM) CEO sells 50,000 shares after option exercise
What happened Beam Therapeutics Inc. (NASDAQ: BEAM) chief executive and director John M. Evans sold 50,000 shares from 2026-10-15 to 2026-10-16 at $23.57 to $23.98 each. The Form 4 says the shares were sold under a Rule 10b5-1 trading plan. It also says the shares came from stock options exercised the same day. The sale […]
Alector (NASDAQ: ALEC) prices shares at a 7.3% premium in stock sale
What happened Alector, Inc. (NASDAQ: ALEC) priced an underwritten offering of 36,600,000 shares of common stock on October 16, 2026. The shares are priced at $2.05 each, and Alector expects gross proceeds of $75.03 million before underwriting discounts, commissions and other estimated offering expenses. All of the shares are being sold by Alector. The financing […]
last updated on 18 Oct 22:07